Medline, Inc. Class A (MDLN)
NASDAQ:MDLN
Want to see MDLN full AI Analyst Report?
MDLN Stock Chart & Stats
$47.64
--
Market closed
$47.64
--
Day’s Range― - ―
52-Week Range$32.82 - $50.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)12.49M
Market Cap
$49.04B
Enterprise Value$41.76B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$12.64B
Price to Earnings (P/E)31.5
Beta1.34
Next Earnings
Aug 06, 2026EPS Estimate
0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.21
Shares Outstanding845,606,200
10 Day Avg. Volume11,964,805
30 Day Avg. Volume12,487,356
Financial Highlights & Ratios
PEG Ratio-4.97
Price to Book (P/B)3.18
Price to Sales (P/S)1.20
P/FCF Ratio26.29
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue1.43
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda15.29
Forecast
1Y Price Target
$51.95Price Target Upside9.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
EPS Forecast (FY)1.51
Revenue Forecast (FY)$31.08B
Bulls Say, Bears Say
Bulls Say
Revenue Scaling And Margin ExpansionSustained top-line growth alongside a multi-percentage-point gross margin rise signals durable improvements in pricing, mix, and cost control. Over 2–6 months this supports higher incremental profitability, more operating leverage as volumes scale, and greater capacity to reinvest in distribution and product offerings.
Solid Cash Generation And Improving Free Cash FlowConsistent OCF and a material improvement in free cash flow provide durable funding for capex, working capital, and debt service. The stronger 2025 FCF conversion reduces immediate refinancing pressure and supports strategic flexibility over the medium term, enabling reinvestment or gradual deleveraging.
Strong Shareholder Support And Governance AlignmentBroad investor backing of the board, auditor, and annual say-on-pay strengthens governance and accountability. This continuity of leadership and enhanced shareholder oversight reduces governance risk, aiding consistent strategy execution and stable management decision-making over the coming quarters.
Bears Say
Elevated Leverage And Rising Debt-to-equityA materially higher leverage profile reduces financial flexibility and increases susceptibility to cash-flow shocks. With debt roughly matching or exceeding equity and leverage rising in 2025, the company faces greater covenant and refinancing risk, limiting ability to fund growth or absorb demand disruptions.
Inconsistent Earnings-to-cash ConversionWhen OCF persistently trails net income it signals working-capital timing or non-cash earnings components that weaken earnings quality. This inconsistency raises the risk that reported profits won't reliably convert to cash, complicating debt service, capex planning, and dividend/return capacity in stress scenarios.
Refinancing And Large Secondary Offering Reinforce Secured Leverage And OverhangThe May 2026 refinancing extended maturities but increased secured obligations and covenanted collateral, structurally raising secured-leverage profile. The sizable secondary offering by sponsors shifts ownership and can create lingering supply or governance complexities, constraining capital allocation flexibility.
Medline News
MDLN FAQ
What was Medline, Inc. Class A’s price range in the past 12 months?
Medline, Inc. Class A lowest stock price was $32.81 and its highest was $50.88 in the past 12 months.
What is Medline, Inc. Class A’s market cap?
Medline, Inc. Class A’s market cap is $49.04B.
When is Medline, Inc. Class A’s upcoming earnings report date?
Medline, Inc. Class A’s upcoming earnings report date is Aug 06, 2026 which is in 49 days.
How were Medline, Inc. Class A’s earnings last quarter?
Medline, Inc. Class A released its earnings results on May 06, 2026. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.295 by $0.035.
Is Medline, Inc. Class A overvalued?
According to Wall Street analysts Medline, Inc. Class A’s price is currently Undervalued.
Does Medline, Inc. Class A pay dividends?
Medline, Inc. Class A does not currently pay dividends.
What is Medline, Inc. Class A’s EPS estimate?
Medline, Inc. Class A’s EPS estimate is 0.32.
How many shares outstanding does Medline, Inc. Class A have?
Medline, Inc. Class A has 845,606,200 shares outstanding.
What happened to Medline, Inc. Class A’s price movement after its last earnings report?
Medline, Inc. Class A reported an EPS of $0.33 in its last earnings report, beating expectations of $0.295. Following the earnings report the stock price went down -7.304%.
Which hedge fund is a major shareholder of Medline, Inc. Class A?
Currently, no hedge funds are holding shares in MDLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medline Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$51.95 (9.04% Upside)
$51.95 (9.04% Upside)
Blogger Sentiment
Bullish
MDLN Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 7.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.6B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 2.3%
Last 30 Days ▼ 2.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Company Description
Medline, Inc. Class A
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
MDLN Company Deck
MDLN Earnings Call
Q1 2026
0:00 / 0:00
MDLN Stock 12 Month Forecast
Average Price Target
$51.95
▲(9.04% Upside)
Baxter International
―
Becton Dickinson
―
ICU Medical
―
Merit Medical Systems
―
Teleflex
―